Back

Conclusion.

23 May 2022 (18:32 - 18:35)
Organised by:
Congress Presentation Part of: SGLT2 inhibition across the spectrum of heart failure: maximizing patient benefits in clinical practice Chronic Heart Failure Open Access Heart Failure 2022

About the speaker

Photo
Professor Carolyn S P Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)

5 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Professor S. Anker (Berlin, DE)
Slides Video
Presentation thumbnail
Optimizing foundational therapies in HF ‒ can we do better?
Professor A. Stewart Coats (Sydney, AU)
Slides Video
Presentation thumbnail
SGLT2 inhibition ‒ early, first-line therapy across the spectrum of HF.
Doctor D. Tomasoni (Brescia, IT)
Slides Video
Presentation thumbnail
SGLT2 inhibition in patients with HFpEF ‒ a case-based discussion.
Professor G. Rosano (London, GB)
Slides Video
Presentation thumbnail
Interactive panel discussion.
Professor S. Anker (Berlin, DE) Professor A. Stewart Coats (Sydney, AU) Professor G. Rosano (London, GB) Doctor D. Tomasoni (Brescia, IT)
Video

Access the full session

Session thumbnail
SGLT2 inhibition across the spectrum of heart failure: maximizing patient benefits in clinical practice
Video

The Event

Event poster

Heart Failure 2022

23 May 2022 18:32 CET
You may be interested in
thumbnail
Congress Presentation
Conclusion.
23 May 2022
thumbnail
Congress Session
SGLT-2 inhibitors - Another piece of the puzzle in heart failure
29 August 2022
thumbnail
Congress Presentation
Summary and close.
21 May 2022
thumbnail
Congress Presentation
Closing of the session - DAPA-HF and DELIVER / DELIVER and EMPEROR-Preserved .
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources